42254-0212
                        
                    
                            Ondansetron
                        
                    
                                    Ondansetron
                                
                            
                        
                    
                            TABLET, ORALLY DISINTEGRATING
                        
                    
                                    Oral
                                
                            
                        
                    
                                     Ondansetron
                                
                                
                                     8.0
                                
                                
                                     mg/1
                                
                                
                            
                        
                    
                                     42254-0212-10
                                
                                
                                     10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (42254-212-10)
                                
                                
                                     June 27, 2007
                                
                                
                                    Ancillary Therapy
                                
                            
                        
                    
                                    Antiemetic
                                
                            
                        
                    
                                    5HT3 Receptor Antagonist
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    